Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19

BACKGROUND: Thrombosis and inflammation may contribute to morbidity and mortality among patients with coronavirus disease 2019 (Covid-19). We hypothesized that therapeutic-dose anticoagulation would improve outcomes in critically ill patients with Covid-19. METHODS: In an open-label, adaptive, multi...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362592/
https://www.ncbi.nlm.nih.gov/pubmed/34351722
http://dx.doi.org/10.1056/NEJMoa2103417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362592/
https://www.ncbi.nlm.nih.gov/pubmed/34351722
http://dx.doi.org/10.1056/NEJMoa2103417

Ejemplares similares